Beyond its local effects on surrounding cells that contribute to sustained skin inflammation, excessively released IL‐1β can spill over in the systemic circulation of patients with RDEB, affect remote organs, and contribute to life-threatening RDEB complications such as amyloidosis and kidney and heart involvement (24–27). The gene discussed is IL1B; the disease is recessive dystrophic epidermolysis bullosa.